ECHO THERAPEUTICS, INC. NEW COMMON STOCK (DE)
ECTE
ECTE was delisted on the 11th of July, 2016.
28 hedge funds and large institutions have $2.33M invested in ECHO THERAPEUTICS, INC. NEW COMMON STOCK (DE) in 2013 Q4 according to their latest regulatory filings, with 7 funds opening new positions, 4 increasing their positions, 6 reducing their positions, and 2 closing their positions.
250% more first-time investments, than exits
New positions opened: 7 | Existing positions closed: 2
22% more funds holding
Funds holding: 23 → 28 (+5)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
28% less capital invested
Capital invested by funds: $3.24M → $2.33M (-$909K)
33% less repeat investments, than reductions
Existing positions increased: 4 | Existing positions reduced: 6
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Jane Street
New York
|
+$41.1K |
| 2 |
CS
Credit Suisse
Zurich,
Switzerland
|
+$35.8K |
| 3 |
VKH
Virtu KCG Holdings
New York
|
+$34.3K |
| 4 |
Royal Bank of Canada
Toronto,
Ontario, Canada
|
+$16.7K |
| 5 |
EWM
Edge Wealth Management
New York
|
+$8.37K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PM
Platinum Management
New York
|
-$1.25M |
| 2 |
MA
MUFG Americas
New York
|
-$30K |
| 3 |
Renaissance Technologies
New York
|
-$23.2K |
| 4 |
Morgan Stanley
New York
|
-$10.2K |
| 5 |
U
UBS
Zurich,
Switzerland
|
-$7.67K |
ECTE Hedge Fund Activity: Q4 2013 in Review
28 of the 3,445 institutional investors tracked by Wall St. Rank reported a position in ECHO THERAPEUTICS, INC. NEW COMMON STOCK (DE) (ECTE) for Q4 2013, worth a combined $2.33M — down 28% from $3.24M a quarter earlier.
Buyers outnumbered sellers: 7 funds opened new ECTE positions and 2 closed out — a net gain of 5 holders — while 4 added to existing stakes and 6 trimmed.
The largest buyer was Jane Street, opening a new position worth an estimated $41.1K. The largest seller was Platinum Management, exiting entirely with an estimated $1.25M sold.
- 28 institutional investors held ECHO THERAPEUTICS, INC. NEW COMMON STOCK (DE) (ECTE) as of Q4 2013, up from 23 in Q3 2013.
- Funds reported $2.33M of ECHO THERAPEUTICS, INC. NEW COMMON STOCK (DE) stock for Q4 2013, down 28% quarter-over-quarter.
- 7 funds opened new ECHO THERAPEUTICS, INC. NEW COMMON STOCK (DE) positions in Q4 2013 and 2 closed out, a net change of +5 holders.
- The largest ECHO THERAPEUTICS, INC. NEW COMMON STOCK (DE) buyer in Q4 2013 was Jane Street, an estimated $41.1K added.
- The largest ECHO THERAPEUTICS, INC. NEW COMMON STOCK (DE) seller in Q4 2013 was Platinum Management, an estimated $1.25M sold.
Based on aggregated 13F filings for Q4 2013.